Clinical Trials Move In: New Medication Studies for Vulva Pain Take Centre Stage – Why London is Leading the Way in Vulva Pain Research?

Sought by Vulva Pain sufferers from across the UK and parts of Europe, here at the London Vulva Pain Clinic, our world-class Vulva Doctors, who are renowned for keeping abreast of the latest cutting-edge research on vulva pain and the latest innovative treatments, therapies and injectables, know only too well about the months and years of waiting for help and lack of support and poor acknowledgement that many patients receive from their general practitioner (GP). Indeed, just a quick search on the internet shows that this totally unacceptable scenario is widespread, with some vulvodynia sufferers even being told that “it is all in their head.”

In the UK, on examining the cold hard facts of the matter, the reality is that, unlike experienced Pain Doctors, the majority of GPs have not undergone the crucial additional years of training and in-house clinical practice and expertise. This is required for:

  • Recognising or suspecting the root cause of the patient’s pain by reviewing their medical and sexual history, asking pertinent questions, spending time listening to them, and conducting a comprehensive examination using the latest tests and scans using state-of-the-art technology
  • Providing them with a research-backed multifaceted protocol which shows that multiple treatments carried out simultaneously have a synergetic effect, which optimises results. For example, here at the London Pain Clinic, our Vulva Consultants (who patients can speak to either in-person or online), provide a Holistic Personalised Treatment Plan which patients can get started on as soon as they have received an accurate diagnosis. This is likely to incorporate the latest research-backed medications, leading-edge therapies, and injectables; as well as nutrition and lifestyle guidance

The Low-Down On Vulvodynia?

As our Pain Specialists explain, vulvodynia can be described as vulvar pain that is experienced by women (or those who were born women), for at least three months. It impacts “up to 16% of women worldwide, translating into countless thousands of women searching for effective treatments, yet only 50% ever receive an accurate diagnosis” [1]. Inciting elements for persistent vulvar pain, incorporate:

  • An individual’s genetic predisposition
  • Changes in hormonal status,
  •  Inflammation
  • Dysfunction of the musculoskeletal system (such as hypertonic pelvic floor muscles), neurologic dysfunction (peripheral or central), anatomical anomalies, and psychosocial factors [1]

Moreover, due to the fact that multiple factors are frequently linked with the maintenance and development of vulvodynia, “identification of the relevant factors in each individual has important treatment implications” [1], yet another reason why consulting a Vulva Doctor is so important.

Putting a Spotlight on New Medication Studies for Vulva Pain

This much needed research to help vulva pain patients, currently spans:

  • Oral pharmaceuticals. Of note, a potential new medication (which has shown potential for neuropathic pain), named Pudafensine,(IPVU2025), has been developed by Initiator Pharma. The latter has applied to commence a Phase 2a clinical trial for this in the UK, and it is anticipated that enrolment will begin by December 2025 pain-relieving effects and safety)
  • Topical medication treatments
  • Injectables backed by research, such as pain blockers and Botox. (For example, studies have indicated that injections of the latter into the pelvic floor muscles, can disrupt pain signals and relax tense muscles, thereby decreasing pain and revving up sexual function in patients with vestibulodynia. Moreover, one Phase 2 trial which finalised in April 2023, determined that that injections of incobotulinumtoxinA are promising. Note: vestibulodynia refers to pain that occurs at the vestibule (entrance) of the vagina. In addition to the aforementioned, a patient may also experience pain in other external parts of their vulva or genitals. Furthermore, vestibulodynia is a category of vulvodynia, or serious chronic vulvar pain, that can arise for no apparent reason).

Reference

[1]. Kellogg-Spadt, S. (2020). “Treatment of Vulvar Pain: A Worthwhile Clinical Challenge.” Harvard Education.

https://info.primarycare.hms.harvard.edu/perspectives/articles/treatment-vulvar-pain#:~:text=Muscle%20relaxants:%20Various%20studies%20have,use%20of%20anti%2Dinflammatory%20agents.